We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Clinical parameters predicting development of pulmonary malignancies in patients treated for head and neck squamous cell carcinoma.
- Authors
Madana, Jeevanandham; Morand, Grégoire B.; Alrasheed, Abdulaziz; Gabra, Nathalie; Laliberté, Frédérick; Barona–Lleó, Luz; Yolmo, Deeke; Black, Martin J.; Sultanem, Khalil; Hier, Michael P.
- Abstract
Background As the locoregional control rates in head and neck squamous cell carcinoma (HNSCC) have increased, these patients may suffer distant metastasis in a higher proportion of cases. Clinicopathological characteristics allowing prediction of high-risk profile would allow adapting posttreatment surveillance to individual risk. Methods A retrospective review of all patients with HNSCC treated at the Jewish General Hospital, McGill University, Montreal, Quebec, Canada, between 1999 and 2008 was conducted for this study. Results The study included 428 patients with a mean follow-up of 65 months (±SEM 1.7). Eighty patients (18.6%) developed pulmonary malignancy during follow-up. In multivariate Cox-regression analysis, locoregional failure and current smoking were associated with higher risk of pulmonary malignancy ( p < .001 and p = .008, respectively). Conclusion Locoregional failure and smoking persistence are predictors of pulmonary malignancy in patients with HNSCC. © 2015 Wiley Periodicals, Inc. Head Neck 38: E1277-E1280, 2016
- Subjects
HEAD &; neck cancer; SQUAMOUS cell carcinoma; LUNG cancer; METASTASIS; SMOKING
- Publication
Head & Neck, 2016, Vol 38, pE1277
- ISSN
1043-3074
- Publication type
Article
- DOI
10.1002/hed.24210